Skip to main content
. 2020 Jan 27;21(5):299–308. doi: 10.1111/hiv.12826

Figure 5.

Figure 5

Adjusted incidence rate ratio and 95% confidence intervals for the association between chronic kidney disease (CKD) development and a one‐point increase in the continuous CKD full risk score. *Modelling in the Data Collection on Adverse Events of Anti‐HIV Drugs (D:A:D) derivation cohort was adjusted for baseline injecting drug use, gender, hepatitis C virus coinfection, age, nadir CD4 count, estimated glomerular filtration rate (eGFR), hypertension, prior cardiovascular disease (CVD) and diabetes. Models in all other cohorts were not further adjusted.